名稱(chēng) | AI-Edigene® EGFR p.L858R Reference標(biāo)準(zhǔn)品 |
型號(hào) | CBP10408 |
報(bào)價(jià) | ![]() |
特點(diǎn) | AI-Edigene® EGFR p.L858R Reference標(biāo)準(zhǔn)品 |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- GLP1R藥靶篩選模型應(yīng)用展示
- 非小細(xì)胞肺癌免疫治療 先放療更有效
- 血液系統(tǒng)惡性腫瘤治療研究熱點(diǎn)
- 購(gòu)買(mǎi)細(xì)胞株前需要了解的相關(guān)技術(shù)知識(shí)
- 增強(qiáng)腫瘤免疫療法新靶點(diǎn):ADORA2B(腺苷A2B受體)
- 基于納米顆粒的組合免疫療法對(duì)致命性癌癥發(fā)起三重打擊
- 探討腫瘤細(xì)胞的“冷與熱”之分
- ctDNA液體活檢診斷標(biāo)準(zhǔn)品
- NCRI:新型檢測(cè)技術(shù)或能提前8年診斷出食管癌
- 腫瘤細(xì)胞分裂“制動(dòng)系統(tǒng)”相關(guān)基因分析
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Mutation > CBP10408AI-Edigene® EGFR p.L858R Reference標(biāo)準(zhǔn)品

- 詳細(xì)內(nèi)容
" _ue_custom_node_="true">
CBP10408 | |
Format | Genomic DNA |
Description | EGFR L858R lies within the protein kinase domain of the Egfr protein (UniProt.org). L858R results in increased kinase activity, is transforming in cell culture (PMID: 29533785), and promotes tumor formation in mouse models (PMID: 16187797). |
Technical Data | |
DNA Change | c.2573T>G |
AA Change | p.L858R |
Mutation type | Substitution - Missense |
Zygosity | Heterozygous |
Allelic Frequency | 50% |
Transcript | ENST00000275493 |
Cosmic ID | COSM6224 |
Chr position(GRCh37) | chr7:55259515 |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purofication | Download for COA |
DNA electrophoresis | Download for COA |
Sanger sequencing | |
Storage | 4℃ |
Expiry | 36 months from the date of manufacture |